SXSW 2020

Reversing Diabetes with Continuous Remote Care

Description:

Type 2 diabetes (T2D) is one of the biggest global health challenges of the 21st century. Half of US adults have T2D or prediabetes, costing $400 billion per year. T2D is assumed to be chronic and irreversible, but diabetes reversal, and reducing or completely stopping diabetes medication, are the goals of the Virta Treatment, a physician-supervised medical nutrition therapy where patients get near on-demand care, wherever they are, to help return to a diabetes-free life. Using Virta’s novel, tech-enabled, continuous remote care platform, Virta Health Medical Director Dr. Jeff Stanley helps patients follow Virta’s individualized nutrition therapy to safely and sustainably reverse type 2 diabetes. Virta’s approach and transformational outcomes are reshaping how we think of chronic disease.


Related Media

Additional Supporting Materials

Other Resources / Information


Takeaways

  1. 2-year clinical trial results, including how 55% reversed their diabetes (HbA1c <6.5%) and how 67% eliminated diabetes-specific medications.
  2. Why Dr. Stanley and other Virta physicians reject the idea that type 2 diabetes is a chronic and progressive disease.
  3. How Virta’s continuous remote care model upends traditional chronic disease care and is paving the way for a paradigm shift in medicine.

Speakers


Organizer

Justine Pallas, Manager, cred


Meta Information:

  • Event: SXSW
  • Format: Focus15
  • Track: Health & MedTech
  • Track 2
  • Level: Intermediate


Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.